Clin Mol Hepatol.
2023 Apr;29(2):411-413. 10.3350/cmh.2023.0058.
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
- Affiliations
-
- 1Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- KMID: 2541431
- DOI: http://doi.org/10.3350/cmh.2023.0058
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
- Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessment
- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
- Histologic Risk Factor for Mortality and Development of Severe Liver Disease in Biopsy-proven Non-alcoholic Fatty Liver Disease
- Clinical impact of nonalcoholic fatty liver disease on other medical diseases
